Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Response to Letter by Moghissi and Calderone.

Shore RE, Beck HL, Boice JD Jr, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

Health Phys. 2019 Aug;117(2):224-225. doi: 10.1097/HP.0000000000001107. No abstract available.

PMID:
31219905
2.

Reply to Comment on 'Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection'.

Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

J Radiol Prot. 2019 Jun;39(2):655-659. doi: 10.1088/1361-6498/ab077f. Epub 2019 May 24. No abstract available.

PMID:
31125317
3.

Medical Radiation Exposure among Atomic Bomb Survivors: Understanding its Impact on Risk Estimates of Atomic Bomb Radiation.

Sadakane A, Landes RD, Sakata R, Nagano J, Shore RE, Ozasa K.

Radiat Res. 2019 Jun;191(6):507-517. doi: 10.1667/RR15054.1. Epub 2019 Mar 29.

4.

Updated mortality analysis of the Mallinckrodt uranium processing workers, 1942-2012.

Golden AP, Ellis ED, Cohen SS, Mumma MT, Leggett RW, Wallace PW, Girardi D, Watkins JP, Shore RE, Boice JD.

Int J Radiat Biol. 2019 Jan 17:1-21. doi: 10.1080/09553002.2019.1569773. [Epub ahead of print]

PMID:
30652958
5.

Recent Epidemiologic Studies and the Linear No-Threshold Model For Radiation Protection-Considerations Regarding NCRP Commentary 27.

Shore RE, Beck HL, Boice JD Jr, Caffrey EA, Davis S, Grogan HA, Mettler FA Jr, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

Health Phys. 2019 Feb;116(2):235-246. doi: 10.1097/HP.0000000000001015.

PMID:
30585971
6.

THE DOSE AND DOSE-RATE EFFECTIVENESS FACTOR (DDREF).

Wakeford R, Azizova T, Dörr W, Garnier-Laplace J, Hauptmann M, Ozasa K, Rajaraman P, Sakai K, Salomaa S, Sokolnikov M, Stram D, Sun Q, Wojcik A, Woloschak G, Bouffler S, Grosche B, Kai M, Little MP, Shore RE, Walsh L, Rühm W.

Health Phys. 2019 Jan;116(1):96-99. doi: 10.1097/HP.0000000000000958. No abstract available.

PMID:
30489371
7.

Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann Cohort.

Adams MJ, Fisher SG, Lipshultz SE, Shore RE, Constine LS, Stovall M, Dozier A, Thevenet-Morrison K, Block R, Schwartz RG, Pearson TA.

Cardiooncology. 2018;4. pii: 1. doi: 10.1186/s40959-018-0027-0. Epub 2018 Feb 17.

8.

Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection.

Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, Walsh L, Dauer LT.

J Radiol Prot. 2018 Sep;38(3):1217-1233. doi: 10.1088/1361-6498/aad348. Epub 2018 Jul 13.

PMID:
30004025
9.

Dosimetry is Key to Good Epidemiology: Workers at Mallinckrodt Chemical Works had Seven Different Source Exposures.

Ellis ED, Boice JD Jr, Golden AP, Girardi DJ, Cohen SS, Mumma MT, Shore RE, Leggett RW, Kerr GD.

Health Phys. 2018 Apr;114(4):386-397. doi: 10.1097/HP.0000000000000847.

PMID:
29481529
10.

The Past Informs the Future: An Overview of the Million Worker Study and the Mallinckrodt Chemical Works Cohort.

Boice JD Jr, Ellis ED, Golden AP, Girardi DJ, Cohen SS, Chen H, Mumma MT, Shore RE, Leggett RW.

Health Phys. 2018 Apr;114(4):381-385. doi: 10.1097/HP.0000000000000825.

PMID:
29481528
11.

A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation.

McLean AR, Adlen EK, Cardis E, Elliott A, Goodhead DT, Harms-Ringdahl M, Hendry JH, Hoskin P, Jeggo PA, Mackay DJC, Muirhead CR, Shepherd J, Shore RE, Thomas GA, Wakeford R, Godfray HCJ.

Proc Biol Sci. 2017 Sep 13;284(1862). pii: 20171070. doi: 10.1098/rspb.2017.1070. Review.

12.

Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.

Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS, Woods M, Liang X, Bernstein JL; WECARE Study Collaborative Group.

Int J Cancer. 2017 Sep 1;141(5):916-924. doi: 10.1002/ijc.30791. Epub 2017 May 31.

13.

Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.

Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF, Woods M, Liang X, Haile RW, Duggan DJ, Shore RE, Smith SA, Thomas DC, Stram DO, Bernstein JL; WECARE Study Collaborative Group.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx051.

14.

Radiation and cataract risk: Impact of recent epidemiologic studies on ICRP judgments.

Shore RE.

Mutat Res. 2016 Oct - Dec;770(Pt B):231-237. doi: 10.1016/j.mrrev.2016.06.006. Epub 2016 Jun 23. Review.

PMID:
27919333
15.

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.

Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M; WECARE Study Collaborative Group, Bernstein JL.

Cancer Med. 2016 Nov;5(11):3282-3291. doi: 10.1002/cam4.890. Epub 2016 Oct 3.

16.

Dose-rate effects in radiation biology and radiation protection.

Rühm W, Azizova TV, Bouffler SD, Little MP, Shore RE, Walsh L, Woloschak GE.

Ann ICRP. 2016 Jun;45(1_suppl):262-279. doi: 10.1177/0146645316629336.

PMID:
26960819
17.

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.

Clendenen TV, Ge W, Koenig KL, Axelsson T, Liu M, Afanasyeva Y, Andersson A, Arslan AA, Chen Y, Hallmans G, Lenner P, Kirchhoff T, Lundin E, Shore RE, Sund M, Zeleniuch-Jacquotte A.

PLoS One. 2015 Oct 21;10(10):e0140478. doi: 10.1371/journal.pone.0140478. eCollection 2015.

18.

Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection.

Rühm W, Woloschak GE, Shore RE, Azizova TV, Grosche B, Niwa O, Akiba S, Ono T, Suzuki K, Iwasaki T, Ban N, Kai M, Clement CH, Bouffler S, Toma H, Hamada N.

Radiat Environ Biophys. 2015 Nov;54(4):379-401. doi: 10.1007/s00411-015-0613-6. Epub 2015 Sep 5.

PMID:
26343037
19.

Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology.

Clendenen TV, Rendleman J, Ge W, Koenig KL, Wirgin I, Currie D, Shore RE, Kirchhoff T, Zeleniuch-Jacquotte A.

PLoS One. 2015 Aug 14;10(8):e0135943. doi: 10.1371/journal.pone.0135943. eCollection 2015.

20.

A report from the 2013 international symposium: the evaluation of the effects of low-dose radiation exposure in the life span study of atomic bomb survivors and other similar studies.

Grant EJ, Ozasa K, Ban N, de González AB, Cologne J, Cullings HM, Doi K, Furukawa K, Imaoka T, Kodama K, Nakamura N, Niwa O, Preston DL, Rajaraman P, Sadakane A, Saigusa S, Sakata R, Sobue T, Sugiyama H, Ullrich R, Wakeford R, Yasumura S, Milder CM, Shore RE.

Health Phys. 2015 May;108(5):551-6. doi: 10.1097/HP.0000000000000262.

PMID:
25811153
21.

Comments on Estimating Risks of Low Radiation Doses-A Critical Review of the BEIR VII Report and Its Use of the Linear No-Threshold (LNT) Hypothesis by Edward J. Calabrese and Michael K. O'Connor.

Crowley KD, Cullings HM, Landes RD, Shore RE, Ullrich RL.

Radiat Res. 2015 Apr;183(4):476-81. doi: 10.1667/RR4029.1. Epub 2015 Mar 25. No abstract available.

PMID:
25807319
22.

Long-term effects of the rain exposure shortly after the atomic bombings in Hiroshima and Nagasaki.

Sakata R, Grant EJ, Furukawa K, Misumi M, Cullings H, Ozasa K, Shore RE.

Radiat Res. 2014 Dec;182(6):599-606. doi: 10.1667/RR13822.1.

PMID:
25402555
23.

A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.

Walsh L, Zhang W, Shore RE, Auvinen A, Laurier D, Wakeford R, Jacob P, Gent N, Anspaugh LR, Schüz J, Kesminiene A, van Deventer E, Tritscher A, del Rosarion Pérez M.

Radiat Res. 2014 Nov;182(5):556-72. doi: 10.1667/RR13779.1. Epub 2014 Sep 24.

PMID:
25251702
24.

Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.

Arslan AA, Koenig KL, Lenner P, Afanasyeva Y, Shore RE, Chen Y, Lundin E, Toniolo P, Hallmans G, Zeleniuch-Jacquotte A.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1290-7. doi: 10.1158/1055-9965.EPI-14-0009. Epub 2014 Apr 27.

25.

Radiation impacts on human health: certain, fuzzy, and unknown.

Shore RE.

Health Phys. 2014 Feb;106(2):196-205. doi: 10.1097/HP.0000000000000021. Review.

PMID:
24378493
26.

Radiation exposure and the risk of mortality from noncancer respiratory diseases in the life span study, 1950-2005.

Pham TM, Sakata R, Grant EJ, Shimizu Y, Furukawa K, Takahashi I, Sugiyama H, Kasagi F, Soda M, Suyama A, Shore RE, Ozasa K.

Radiat Res. 2013 Nov;180(5):539-45. doi: 10.1667/RR13421.1. Epub 2013 Oct 23.

PMID:
24148011
27.

Ninth Annual Warren K. Sinclair Keynote Address: effects of childhood radiation exposure: an issue from computed tomography scans to Fukushima.

Mettler FA Jr, Constine LS, Nosske D, Shore RE.

Health Phys. 2013 Nov;105(5):424-9. doi: 10.1097/HP.0b013e31829c3548.

PMID:
24077040
28.

Genetic variants in hormone-related genes and risk of breast cancer.

Clendenen T, Zeleniuch-Jacquotte A, Wirgin I, Koenig KL, Afanasyeva Y, Lundin E, Arslan AA, Axelsson T, Försti A, Hallmans G, Hemminki K, Lenner P, Roy N, Shore RE, Chen Y.

PLoS One. 2013 Jul 23;8(7):e69367. doi: 10.1371/journal.pone.0069367. Print 2013.

29.

Uncertainties in estimating health risks associated with exposure to ionising radiation.

Preston RJ, Boice JD Jr, Brill AB, Chakraborty R, Conolly R, Hoffman FO, Hornung RW, Kocher DC, Land CE, Shore RE, Woloschak GE.

J Radiol Prot. 2013 Sep;33(3):573-88. doi: 10.1088/0952-4746/33/3/573. Epub 2013 Jun 27.

PMID:
23803503
30.

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group.

Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.

31.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

32.

Invited commentary: missing doses in the life span study of Japanese atomic bomb survivors.

Ozasa K, Grant EJ, Cullings HM, Shore RE.

Am J Epidemiol. 2013 Mar 15;177(6):569-73. doi: 10.1093/aje/kws474. Epub 2013 Feb 20.

PMID:
23429724
33.

The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.

Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, Iwanaga M, Miyazaki Y, Cullings HM, Suyama A, Ozasa K, Shore RE, Mabuchi K.

Radiat Res. 2013 Mar;179(3):361-82. doi: 10.1667/RR2892.1. Epub 2013 Feb 11.

34.

Circulating prolactin levels and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2013 Apr;24(4):741-8. doi: 10.1007/s10552-013-0156-6. Epub 2013 Feb 3.

35.

ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.

Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, Macvittie TJ, Aleman BM, Edgar AB, Mabuchi K, Muirhead CR, Shore RE, Wallace WH.

Ann ICRP. 2012 Feb;41(1-2):1-322. doi: 10.1016/j.icrp.2012.02.001. Review.

PMID:
22925378
36.

Radiation effects on cancer risks in the Life Span Study cohort.

Kodama K, Ozasa K, Katayama H, Shore RE, Okubo T.

Radiat Prot Dosimetry. 2012 Oct;151(4):674-6. Epub 2012 Aug 19.

PMID:
22908358
37.

Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005.

Neriishi K, Nakashima E, Akahoshi M, Hida A, Grant EJ, Masunari N, Funamoto S, Minamoto A, Fujiwara S, Shore RE.

Radiology. 2012 Oct;265(1):167-74. Epub 2012 Aug 8. Erratum in: Radiology. 2012 Dec;265(3):981.

PMID:
22875798
38.

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995.

Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr.

Radiat Res. 2012 Aug;178(2):AV43-60. No abstract available.

PMID:
22870979
39.

Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, Axelsson T, Hemminki K, Clendenen TV, Arslan AA, Ohlson N, Sieri S, Roy N, Koenig KL, Idahl A, Berrino F, Toniolo P, Hallmans G, Försti A, Muti P, Lenner P, Shore RE, Zeleniuch-Jacquotte A.

Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.

40.

Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.

Brooks JD, Boice JD Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, Bernstein JL, Shore RE; WECARE Collaborative Group.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):917-24. doi: 10.1016/j.ijrobp.2012.01.047. Epub 2012 Apr 6.

41.

Premenopausal serum androgens and breast cancer risk: a nested case-control study.

Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, Rinaldi S, Scarmo S, Liu M, Arslan AA, Toniolo P, Shore RE, Koenig KL.

Breast Cancer Res. 2012 Feb 16;14(1):R32.

42.

Factors associated with inflammation markers, a cross-sectional analysis.

Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, Gu Y, Hallmans G, Idahl A, Krogh V, Lokshin AE, Lundin E, Muti P, Marrangoni A, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cytokine. 2011 Dec;56(3):769-78. doi: 10.1016/j.cyto.2011.09.013. Epub 2011 Oct 19.

43.

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.

Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, Toniolo P, Lundin E.

Br J Cancer. 2011 Oct 25;105(9):1458-64. doi: 10.1038/bjc.2011.381. Epub 2011 Sep 27.

44.

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group, Haile RW, Concannon P, Bernstein JL.

Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29.

45.

Body mass index and risk of second primary breast cancer: the WECARE Study.

Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; WECARE Study Collaborative Group, Bernstein JL, Bernstein L.

Breast Cancer Res Treat. 2012 Jan;131(2):571-80. doi: 10.1007/s10549-011-1743-4. Epub 2011 Sep 3.

46.

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE, Strickler HD.

Br J Cancer. 2011 Aug 23;105(5):709-22. doi: 10.1038/bjc.2011.254. Epub 2011 Jul 19.

47.

Implications of radiation epidemiologic data for risk assessment and radiation protection.

Shore RE.

Health Phys. 2011 Mar;100(3):306-8. No abstract available.

PMID:
21595078
48.

Circulating inflammation markers and risk of epithelial ovarian cancer.

Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, Liu M, Shore RE, Arslan AA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):799-810. doi: 10.1158/1055-9965.EPI-10-1180. Epub 2011 Apr 5.

49.

Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.

Douple EB, Mabuchi K, Cullings HM, Preston DL, Kodama K, Shimizu Y, Fujiwara S, Shore RE.

Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S122-33. doi: 10.1001/dmp.2011.21.

50.

Endogenous hormones and coronary heart disease in postmenopausal women.

Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, Levitz M, Koenig KL.

Atherosclerosis. 2011 Jun;216(2):414-9. doi: 10.1016/j.atherosclerosis.2011.01.053. Epub 2011 Mar 1.

Supplemental Content

Loading ...
Support Center